Last reviewed · How we verify
NCT03747107: P-DQIP
Pharmacist and Data Driven Quality Improvement in Primary Care
trial testing P-DQIP in Medication Safety in 19 participants. Completed in 30 June 2021.
30 June 2021
Quick facts
| Lead sponsor | University of Dundee |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 19 |
| Start date | 16 September 2020 |
| Primary completion | 30 June 2021 |
| Estimated completion | 30 June 2021 |
| Sites | 1 location across United Kingdom |
Drugs / interventions tested
- P-DQIP
Conditions studied
- Medication Safety — all drugs for Medication Safety →
Sponsor
University of Dundee
Who can join
Eligibility, any sex, with Medication Safety. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
P-DQIP is an intervention to improve prescribing safety in primary care. The 'intervention' is a health board quality improvement programme that will be implemented across all practices in one National Health Service (NHS) board in Scotland (Tayside), and comprises the following components: i. Case finding of patients with drug therapy risks via the P-DQIP informatics tool ii. Decision support for clinicians when conducting medication reviews via the P-DQIP informatics tool iii. Support from practice pharmacists in reviewing and managing targeted patients iv. Ongoing performance feedback via the P-DQIP informatics tool v. Promotion of the P-DQIP tool and intervention among general practices. The P-DQIP intervention will be evaluated in all NHS Tayside practices who agree to share their data for monitoring and evaluation purposes.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT03747107
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Medication Safety
Currently open trials in the same condition.
- NCT06273761 — Evaluation of Medication Management Service · NA · recruiting
Other University of Dundee trials
Trials by the same sponsor.
- NCT06435156 — Sotagliflozin in Patients With Heart Failure Symptoms and Type 1 Diabetes · Phase 2 · recruiting
- NCT05582798 — Bronchiectasis Alpha-1 Augmentation Trial- Modulating Airway Neutrophil Function · Phase 4 · completed
- NCT04419805 — Single Palatal Temporary Anchorage Device for Anterior Open Bite · NA · unknown
- NCT04817332 — STOP-COVID19: Superiority Trial Of Protease Inhibition in COVID-19 · Phase 3 · completed
- NCT04154163 — Appropriate Dosing to Optimise Personalised Cancer Treatments · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03747107 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of Dundee
- Last refreshed: 10 September 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03747107.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing